Speakers:
Max Palmer, Head of the Cancer Division, MRC Clinical Trials Unit
Kate Law, Director of Clinical Trials, Cancer Research UK
Dr David Glover, expert on monoclonal antibodies and former Chief Medical Officer, Cambridge Antibody Technology (CAT)
Dr Ray Noble, Medical ethicist, sitting on a UCL medical ethics committee
Aisling Burnand, Chief Executive, BioIndustry Association (BIA)
In the wake of the Parexel clinical trial tragedy, the SMC is bringing some of the UK’s leading experts on clinical trials to answer the big questions raised regarding safety of biological treatments (like monoclonal antibodies) and the use of laboratory testing.